3.30 MB - Academy of Medicine of Malaysia

MANAGEMENT OF HIV INFECTION IN CHILDREN
14 Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A, et al. Short-course
therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of
human immunodeficiency virus type 1 in Thailand. Clin Infect Dis. 2002 Dec 1;35(11):
1405-1413.
15 Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al Lamivudine-zidovudine combination
for prevention of maternal-infant transmission of HIV-1. JAMA. 2001 Apr 25;285(16):
2083-2093.
16 Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine
compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in
Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999, 354:795-802.
17 Jackson KE, Jackson WL Jr. The right to health and the nevirapine case in South Africa.
N Engl J Med. 2003 Jun 12;348(24):2470-2471
18 Lallemant M, Jourdain G, Le Coeur S, et al. Perinatal HIV Prevention Trial (Thailand)
Investigators. Single-dose perinatal nevirapine plus standard zidovudine to prevent motherto-child
transmission of HIV-1 in Thailand. N Engl J Med. 2004 Jul 15;351(3):217-228.
19 Dabis F, Balestre E, Braitstein P, et al. The Antiviral Therapy in Lower Income Countries
(ART-LINC) Study Group. Cohort Profile: Antiretroviral Therapy in Lower Income Countries
(ART-LINC): international collaboration of treatment cohorts. Int J Epidemiol. 2005
Oct;34(5):979-986.
20 European Collaborative Study. Mother-to-child transmission of HIV infection in the era of
highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465.
21 Tonwe-Gold B, Ekouevi D, Rouet F, et al. Highly active antiretroviral therapy for the
prevention of perinatal HIV transmission in Africa: Mother-To-Child HIV Transmission Plus,
Abidjan, Côte d'Ivoire, 2003-2004 [abstract 785]. In; Program and abstracts of the 12th
conference of retroviruses and Opportunistic Infections (Boston). Alexandria, VA;
Foundation for Retrovirology and Human Health, 2005.
22 Hawkins D, Blott M, Clayden, P, et al. BHIVA Guidelines Writing Committee. Guidelines for
the management of HIV infection in pregnant women and the prevention of mother-to-child
transmission of HIV. HIV Med, 2005, 6 (Suppl 2), 107-148.
23 Ministry of Health, Malaysia. CPG Management of HIV in Pregnant Women, 2008.
24 Public Health Service Task Force recommendations for use of antiretroviral drugs in
pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal
HIV-1 transmission in the United States. Rockville (MD): U.S. Public Health Service; 2006
Oct 12. 61 p.
25 World Health Organisation (WHO). Technical consultation on the integration of HIV
interventions into maternal, newborn and child health services: Report of a WHO meeting.
Geneva: WHO, 2006.
26 Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1
transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative
Perinatal HIV Transmission Study Group.Lancet 1999;353(9155):773-780
27 Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine
compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in
Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003
Sep 13;362(9387):859-868.
54